vinpocetine has been researched along with Deafness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nekrassov, V; Sitges, M | 1 |
1 other study(ies) available for vinpocetine and Deafness
| Article | Year |
|---|---|
Vinpocetine protects from aminoglycoside antibiotic-induced hearing loss in guinea pig in vivo.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Auditory Pathways; Auditory Threshold; Deafness; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Male; Neuroprotective Agents; Reaction Time; Sodium Channel Blockers; Sodium Channels; Survival Rate; Vinca Alkaloids; Weight Gain | 2000 |